Cargando...

Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study

INTRODUCTION: The IGLU-SIT study documented the effectiveness of initiating supplementary prandial insulin treatment (SIT) with insulin glulisine after failure of oral antidiabetic drugs alone in patients with type 2 diabetes (T2DM) in a real-world setting in Germany. METHODS: The IGLU-SIT study was...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Ther
Main Authors: Pfohl, Martin, Seufert, Jochen, Borck, Anja, Bramlage, Peter, Siegmund, Thorsten
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947113/
https://ncbi.nlm.nih.gov/pubmed/33544355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-00998-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!